Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 179

1.

Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial.

Hamstra DA, Mariados N, Sylvester J, Shah D, Karsh L, Hudes R, Beyer D, Kurtzman S, Bogart J, Hsi RA, Kos M, Ellis R, Logsdon M, Zimberg S, Forsythe K, Zhang H, Soffen E, Francke P, Mantz C, Rossi P, DeWeese T, Daignault-Newton S, Fischer-Valuck BW, Chundury A, Gay H, Bosch W, Michalski J.

Int J Radiat Oncol Biol Phys. 2016 Dec 23. pii: S0360-3016(16)33598-2. doi: 10.1016/j.ijrobp.2016.12.024. [Epub ahead of print]

PMID:
28209443
2.

Bone Marrow-sparing Intensity Modulated Radiation Therapy With Concurrent Cisplatin For Stage IB-IVA Cervical Cancer: An International Multicenter Phase II Clinical Trial (INTERTECC-2).

Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz CC, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ; INTERTECC Study Group..

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):536-545. doi: 10.1016/j.ijrobp.2016.11.027.

PMID:
28126303
3.

Hydrogel spacer distribution within the perirectal space in patients undergoing radiotherapy for prostate cancer: Impact of spacer symmetry on rectal dose reduction and the clinical consequences of hydrogel infiltration into the rectal wall.

Fischer-Valuck BW, Chundury A, Gay H, Bosch W, Michalski J.

Pract Radiat Oncol. 2016 Oct 17. pii: S1879-8500(16)30222-3. doi: 10.1016/j.prro.2016.10.004. [Epub ahead of print]

4.

SU-F-T-237: The Imaging and Radiation Oncology Core (IROC) Cooperatives Activities Supporting the NCI's National Clinical Trial Network.

Followill D, Galvin J, Michalski J, Rosen M, FitzGerald T, Knopp M.

Med Phys. 2016 Jun;43(6):3516-3517. doi: 10.1118/1.4956376.

PMID:
28048701
5.

Highly Efficient Training, Refinement, and Validation of a Knowledge-based Planning Quality-Control System for Radiation Therapy Clinical Trials.

Li N, Carmona R, Sirak I, Kasaova L, Followill D, Michalski J, Bosch W, Straube W, Mell LK, Moore KL.

Int J Radiat Oncol Biol Phys. 2017 Jan 1;97(1):164-172. doi: 10.1016/j.ijrobp.2016.10.005.

PMID:
27979445
6.

Simulated Online Adaptive Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Oligometastatic Disease of the Abdomen and Central Thorax: Characterization of Potential Advantages.

Henke L, Kashani R, Yang D, Zhao T, Green O, Olsen L, Rodriguez V, Wooten HO, Li HH, Hu Y, Bradley J, Robinson C, Parikh P, Michalski J, Mutic S, Olsen JR.

Int J Radiat Oncol Biol Phys. 2016 Dec 1;96(5):1078-1086. doi: 10.1016/j.ijrobp.2016.08.036.

PMID:
27742541
7.

NCCN Guidelines Insights: Bladder Cancer, Version 2.2016.

Clark PE, Spiess PE, Agarwal N, Bangs R, Boorjian SA, Buyyounouski MK, Efstathiou JA, Flaig TW, Friedlander T, Greenberg RE, Guru KA, Hahn N, Herr HW, Hoimes C, Inman BA, Kader AK, Kibel AS, Kuzel TM, Lele SM, Meeks JJ, Michalski J, Montgomery JS, Pagliaro LC, Pal SK, Patterson A, Petrylak D, Plimack ER, Pohar KS, Porter MP, Sexton WJ, Siefker-Radtke AO, Sonpavde G, Tward J, Wile G, Dwyer MA, Smith C.

J Natl Compr Canc Netw. 2016 Oct;14(10):1213-1224.

PMID:
27697976
8.

The world's first single-room proton therapy facility: Two-year experience.

Contreras J, Zhao T, Perkins S, Sun B, Goddu S, Mutic S, Bottani B, Endicott S, Michalski J, Robinson C, Tsien C, Huang J, Fischer-Valuck BW, Hallahan D, Klein E, Bradley J.

Pract Radiat Oncol. 2017 Jan - Feb;7(1):e71-e76. doi: 10.1016/j.prro.2016.07.003.

PMID:
27637138
9.

[Dentigerous cyst: a case report].

Spini RG, Bordino L, Cruz D, Fitz Maurice Mde L, Martins A, Michalski J.

Arch Argent Pediatr. 2016 Oct 1;114(5):e338-42. doi: 10.5546/aap.2016.e338. Spanish.

10.

In Regard to Habl et al.

Fagundes M, Han-Chih Chang J, Michalski J, Soffen E, Davis B, Pisansky T.

Int J Radiat Oncol Biol Phys. 2016 Sep 1;96(1):241-2. doi: 10.1016/j.ijrobp.2016.04.006. No abstract available.

PMID:
27511861
11.

E-DIP: Early Discharge Project. A Model for Throughput and Early Discharge for 1-Day Admissions.

Cho HJ, Desai N, Florendo A, Marshall C, Michalski J, Lee N, Dunn A.

BMJ Qual Improv Rep. 2016 Jun 17;5(1). pii: u210035.w4128. doi: 10.1136/bmjquality.u210035.w4128.

12.

Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.

Acharya S, Fischer-Valuck BW, Kashani R, Parikh P, Yang D, Zhao T, Green O, Wooten O, Li HH, Hu Y, Rodriguez V, Olsen L, Robinson C, Michalski J, Mutic S, Olsen J.

Int J Radiat Oncol Biol Phys. 2016 Feb 1;94(2):394-403. doi: 10.1016/j.ijrobp.2015.10.015.

PMID:
26678659
13.

Role of Automatic Wireless Remote Monitoring Immediately Following ICD Implant: The Lumos-T Reduces Routine Office Device Follow-Up Study (TRUST) Trial.

Varma N, Epstein AE, Schweikert R, Michalski J, Love CJ; TRUST Investigators..

J Cardiovasc Electrophysiol. 2016 Mar;27(3):321-6. doi: 10.1111/jce.12895.

PMID:
26661687
14.

Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.

Movsas B, Hu C, Sloan J, Bradley J, Komaki R, Masters G, Kavadi V, Narayan S, Michalski J, Johnson DW, Koprowski C, Curran WJ Jr, Garces YI, Gaur R, Wynn RB, Schallenkamp J, Gelblum DY, MacRae RM, Paulus R, Choy H.

JAMA Oncol. 2016 Mar;2(3):359-67. doi: 10.1001/jamaoncol.2015.3969.

15.

Patient-reported quality of life after stereotactic body radiotherapy (SBRT), intensity modulated radiotherapy (IMRT), and brachytherapy.

Evans JR, Zhao S, Daignault S, Sanda MG, Michalski J, Sandler HM, Kuban DA, Ciezki J, Kaplan ID, Zietman AL, Hembroff L, Feng FY, Suy S, Skolarus TA, McLaughlin PW, Wei JT, Dunn RL, Finkelstein SE, Mantz CA, Collins SP, Hamstra DA; PROSTQA Study Consortium..

Radiother Oncol. 2015 Aug;116(2):179-84. doi: 10.1016/j.radonc.2015.07.016.

PMID:
26276528
16.

Rebuttal to Drs. Hussein and Cooperberg.

Markovina S, Michalski J.

Brachytherapy. 2015 Nov-Dec;14(6):763-5. doi: 10.1016/j.brachy.2015.06.010. No abstract available.

PMID:
26235200
17.

Counterpoint: Unfair comparisons lead to unwarranted conclusions-Can treatment modalities for localized prostate cancer truly be compared without bias?

Markovina S, Michalski J.

Brachytherapy. 2015 Nov-Dec;14(6):756-60. doi: 10.1016/j.brachy.2015.06.009. No abstract available.

PMID:
26219833
18.

A Phase 3 Trial of 2 Years of Androgen Suppression and Radiation Therapy With or Without Adjuvant Chemotherapy for High-Risk Prostate Cancer: Final Results of Radiation Therapy Oncology Group Phase 3 Randomized Trial NRG Oncology RTOG 9902.

Rosenthal SA, Hunt D, Sartor AO, Pienta KJ, Gomella L, Grignon D, Rajan R, Kerlin KJ, Jones CU, Dobelbower M, Shipley WU, Zeitzer K, Hamstra DA, Donavanik V, Rotman M, Hartford AC, Michalski J, Seider M, Kim H, Kuban DA, Moughan J, Sandler H.

Int J Radiat Oncol Biol Phys. 2015 Oct 1;93(2):294-302. doi: 10.1016/j.ijrobp.2015.05.024.

19.

Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.

Krauss DJ, Hu C, Bahary JP, Souhami L, Gore EM, Chafe SM, Leibenhaut MH, Narayan S, Torres-Roca J, Michalski J, Zeitzer KL, Donavanik V, Sandler H, McGowan DG, Jones CU, Shipley WU.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):863-73. doi: 10.1016/j.ijrobp.2015.03.017.

20.

Quality of Intensity Modulated Radiation Therapy Treatment Plans Using a ⁶⁰Co Magnetic Resonance Image Guidance Radiation Therapy System.

Wooten HO, Green O, Yang M, DeWees T, Kashani R, Olsen J, Michalski J, Yang D, Tanderup K, Hu Y, Li HH, Mutic S.

Int J Radiat Oncol Biol Phys. 2015 Jul 15;92(4):771-8. doi: 10.1016/j.ijrobp.2015.02.057.

PMID:
26104932
Items per page

Supplemental Content

Loading ...
Support Center